Featured Research

from universities, journals, and other organizations

Cellular Antacids Give Vaccines A Boost

Date:
September 13, 2005
Source:
Journal of Experimental Medicine
Summary:
Scientists in Italy have found that a drug that blocks acid buildup inside cells revs up the immune response to vaccines. Reporting in the September 19 issue of The Journal of Experimental Medicine, Vincenzo Barnaba and his team at the University of Rome show that people receiving booster shots against hepatitis B virus developed more robust immune responses if given a widely used anti-malaria drug called chloroquine.

Scientists in Italy have found that a drug that blocks acid buildupinside cells revs up the immune response to vaccines. Reporting in theSeptember 19 issue of The Journal of Experimental Medicine, VincenzoBarnaba and his team at the University of Rome show that peoplereceiving booster shots against hepatitis B virus developed more robustimmune responses if given a widely used anti-malaria drug calledchloroquine.

Many vaccines are made up of soluble proteins derived from dangerousviruses or bacteria. But because of the way these proteins are brokendown by cells, they do a poor job of prodding killer cells calledcytolytic T cells into action. Cytolytic T cells are responsible foridentifying and executing infected cells, so finding ways to get moreof these cells activated is an important goal for vaccine development.

Barnaba and his colleagues now show that exposing cells tochloroquine prevents the acidification of cellular compartments intowhich vaccine proteins are taken up. Normally these proteins would bedigested rapidly inside the compartment, but this is prevented bychloroquine because the degradation requires an acidic environment. Thechloroquine treatment also made the vesicles leaky, allowing theproteins to escape into the cytoplasm of the cell. From there, theycould be broken down such that small pieces of the protein aredisplayed to nearby cytolytic T cells; recognition of these smallpieces of protein activates the killer cells.

The demonstration that a single dose of chloroquine boostedhepatitis B virus-specific T cell responses in up to 70% of vaccinerecipients suggests that this readily available, oral drug might be apromising vaccine supplement.


Story Source:

The above story is based on materials provided by Journal of Experimental Medicine. Note: Materials may be edited for content and length.


Cite This Page:

Journal of Experimental Medicine. "Cellular Antacids Give Vaccines A Boost." ScienceDaily. ScienceDaily, 13 September 2005. <www.sciencedaily.com/releases/2005/09/050913075010.htm>.
Journal of Experimental Medicine. (2005, September 13). Cellular Antacids Give Vaccines A Boost. ScienceDaily. Retrieved September 3, 2014 from www.sciencedaily.com/releases/2005/09/050913075010.htm
Journal of Experimental Medicine. "Cellular Antacids Give Vaccines A Boost." ScienceDaily. www.sciencedaily.com/releases/2005/09/050913075010.htm (accessed September 3, 2014).

Share This



More Health & Medicine News

Wednesday, September 3, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Snack Attack: Study Says Action Movies Make You Snack More

Snack Attack: Study Says Action Movies Make You Snack More

Newsy (Sep. 2, 2014) You're more likely to gain weight while watching action flicks than you are watching other types of programming, says a new study published in JAMA. Video provided by Newsy
Powered by NewsLook.com
U.N. Says Ebola Travel Restrictions Will Cause Food Shortage

U.N. Says Ebola Travel Restrictions Will Cause Food Shortage

Newsy (Sep. 2, 2014) The U.N. says the problem is two-fold — quarantine zones and travel restrictions are limiting the movement of both people and food. Video provided by Newsy
Powered by NewsLook.com
Doctors Fear They're Losing Battle Against Ebola

Doctors Fear They're Losing Battle Against Ebola

AP (Sep. 2, 2014) As a third American missionary is confirmed to have contracted Ebola in Liberia, doctors on the ground in West Africa fear they're losing the battle against the outbreak. (Sept. 2) Video provided by AP
Powered by NewsLook.com
Tech Giants Bet on 3D Headsets for Gaming, Healthcare

Tech Giants Bet on 3D Headsets for Gaming, Healthcare

AFP (Sep. 2, 2014) When Facebook acquired the virtual reality hardware developer Oculus VR in March for $2 billion, CEO Mark Zuckerberg hailed the firm's technology as "a new communication platform." Duration: 02:24 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins